Your activity: 52 p.v.
< Back
your limit has been reached. plz Donate us to allow your ip full access, Email: sshnevis@outlook.com

Five- and ten-year survival rates for patients who underwent resection of a pancreatic neuroendocrine tumor[1]

Five- and ten-year survival rates for patients who underwent resection of a pancreatic neuroendocrine tumor[1]
Stage Observed survival* Relative survival Median survival
(months)
5-year
(percent)		 10-year
(percent)		 5-year
(percent)		 10-year
(percent)
I 61.0 46.0 75.6 71.1 112
II 52.0 28.8 64.3 45.8 63
III 41.4 18.5 60.5 33.1 46
IV 15.5 5.1 19.9 8.9 14
* Comparisons between each stage group are significant to p<0.0001.
¶ Survival adjusted for patient age by matching against 1990 United States Census Bureau data.
References:
  1. Bilimoria KY, Bentrem DJ, Merkow RP, et al: Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors. J Am Coll Surg 2007; 205:558.
Used with the permission of the American Joint Committee on Cancer (AJCC), Chicago, Illinois. The original source for this material is the AJCC Cancer Staging Manual, Seventh Edition (2010) published by Springer New York, Inc.
Graphic 80523 Version 15.0